Realize Medical announced that it received FDA 510(k) clearance for its Elucis virtual reality (VR) software for surgical planning.
The Ottawa, Canada-based startup designed Elucis to enable the quick creation, understanding and sharing of complex anatomy. Medical professionals can do so with CTs and MRIs in an immersive 3D environment.
Elucis lets users connect with other users in a fully functional VR environment, either from within VR or through desktop PCs. Its uses may include improving 3D pre-operative planning and patient consultations.
The company said in a news release that FDA clearance marks “a significant milestone.”
“We’re often told that Elucis represents the most advanced offering in the mixed reality space,” said Realize Medical CEO Justin Sutherland. “But with powerful image processing, modeling, and collaboration tools, it’s also a comprehensive and complete platform for serving the full suite of growing 3D needs in medicine. With FDA clearance, we’re truly excited to enable an expanding era of procedure planning and collaboration.”
Dr. Jenny Zablah, a congenital interventional cardiologist in Colorado, said Elucis helps conceptualize innovative procedures. It offers the end product of successful cases, development of new devices and improved education for patients and families.
Realize Medical said it expects use cases for Elucis to align to the needs of surgeons across all disciplines.
Are you Hiring?
